A study of older adults at heightened risk of dementia has found that those taking high daily doses of vitamin D scored noticeably better on a standard test of memory and thinking than those who did not. Participants reporting at least 5,000 international units of the supplement a day scored more than 13 percent higher on a common cognitive screening tool, even after other factors were taken into account.
The finding adds a new data point to a long and often contradictory research effort into whether the so-called sunshine vitamin can protect the aging brain. Because the study observed a group of people rather than assigning doses in a controlled experiment, its results point to an association worth investigating rather than a proven treatment.
What the researchers measured
The study, conducted by investigators at Emory University, focused on 54 adults who had both sleep disturbances and mild cognitive impairment, two conditions considered early warning signs of dementia. Cognitive performance was assessed using the Montreal Cognitive Assessment, a widely used screening test that gauges memory, attention, language and other thinking skills on a standardized scale.
According to the university’s account of the research, participants who reported taking 5,000 international units or more of vitamin D each day scored more than 13 percent higher on that assessment than those who did not take the supplement at that level. The gap persisted after the analysis adjusted for other variables that might influence cognition.
Why the 5,000 IU threshold stood out
One of the more striking details was that lower doses did not show the same benefit. In this group, only intakes at or above the 5,000 IU daily mark were associated with better cognitive scores, while smaller amounts of vitamin D showed no such link. That pattern suggests, at least within this population, that a threshold effect may be at work, with meaningful benefits appearing only above a certain level of intake.
The threshold finding is important because much of the previous research on vitamin D and the brain used lower doses. If cognitive effects only emerge at higher intakes, studies that tested modest amounts might have missed a benefit that a stronger dose could reveal, which could help explain why earlier results have been so mixed.
A long and conflicting research record
Vitamin D has been studied for years as a possible factor in brain health, with results that rarely line up neatly. As the overview of the nutrient reflects, vitamin D plays roles throughout the body, and receptors for it are found in brain tissue, giving biological plausibility to the idea that it might influence cognition. Yet large trials testing supplementation for various outcomes have often failed to show clear benefits.
That backdrop is why researchers treat a single positive study with caution. Observational findings can be confounded by the fact that people who take high-dose supplements may differ in other ways, such as overall health habits, from those who do not, and only a controlled trial can isolate the effect of the vitamin itself. Vitamin D is unusual among nutrients because the body can manufacture it in the skin during exposure to sunlight, which means blood levels depend on geography, season, skin tone and lifestyle as much as on diet. That complexity has long made it difficult to pin down exactly how much vitamin D the brain needs, and at what level any benefit might appear.
The limits of a small observational study
With just 54 participants, the study is small, and its design cannot establish that vitamin D caused the higher scores. The researchers observed an association within a specific group of people who already had sleep problems and mild cognitive impairment, so the result may not generalize to healthy older adults or to the wider population. Self-reported supplement use also introduces uncertainty about exact doses.
These limitations do not erase the finding, but they frame it. The appropriate conclusion is that high-dose vitamin D deserves testing in a rigorous randomized trial among people at risk of dementia, not that a particular dose has been shown to prevent cognitive decline.
What the finding means for older adults
Vitamin D deficiency is common among older adults, who often get less sun exposure and absorb the nutrient less efficiently, so ensuring adequate levels is already a standard part of geriatric care. The new results raise the possibility that intake could matter for the brain as well as the bones, particularly for those showing early signs of decline.
Because very high doses of vitamin D can carry risks, including elevated calcium levels, decisions about supplementation are best made with a clinician who can weigh an individual’s blood levels and overall health. For now, the study offers an intriguing lead in the search for accessible ways to support cognition in aging, and a clear prompt for larger, more definitive research.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
- Long-term use of common heartburn pills is tied to kidney and dementia risk
- A California supervolcano has bulged upward about two and a half feet since 1978
- The FTC is warning about a scam quietly draining thousands from victims
- The NSA is again telling phone owners to switch off one location setting
